Nastech Pharmaceutical and P&G end collaboration for osteoporosis treatment
Posted by Dr.Osteo on November 9, 2007
Nastech Pharmaceutical Co. (NSTK US) dropped $5, or 36 percent, to $8.99 for the biggest drop since March 2006. The developer of medicines given by nasal spray said Procter & Gamble Co. (PG US) ended a collaboration on the development of a drug to treat the bone-thinning disease osteoporosis. source bloomberg
